Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 20.05.16 in Vol 5, No 2 (2016): Apr-Jun

This paper is in the following e-collection/theme issue:

Works citing "A Decision Aid for Women Considering Neoadjuvant Systemic Therapy for Operable Invasive Breast Cancer: Development and Protocol of a Phase II Evaluation Study (ANZ1301 DOMINO)"

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.5641):

(note that this is only a small subset of citations)

  1. Vromans R, Tenfelde K, Pauws S, van Eenbergen M, Mares-Engelberts I, Velikova G, van de Poll-Franse L, Krahmer E. Assessing the quality and communicative aspects of patient decision aids for early-stage breast cancer treatment: a systematic review. Breast Cancer Research and Treatment 2019;178(1):1
  2. Zdenkowski N, Butow P, Spillane A, Douglas C, Snook K, Jones M, Oldmeadow C, Fewster S, Beckmore C, Boyle FM. Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer. The Breast 2019;46:25
  3. Herrmann A, Boyle F, Butow P, Hall AE, Zdenkowski N. Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer. Health Science Reports 2018;1(1):e13
  4. de Ligt K, Spronk P, van Bommel A, Vrancken Peeters M, Siesling S, Smorenburg C. Patients' experiences with decisions on timing of chemotherapy for breast cancer. The Breast 2018;37:99